These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

643 related items for PubMed ID: 34932284

  • 1. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
    Khat'kova SE, Baikova A, Maisonobe P, Khasanova DR.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):39-48. PubMed ID: 34932284
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
    Turner-Stokes L, Jacinto J, Fheodoroff K, Brashear A, Maisonobe P, Lysandropoulos A, Ashford S, Upper Limb International Spasticity (ULIS-III) study group.
    J Rehabil Med; 2021 Feb 24; 53(2):jrm00157. PubMed ID: 33616192
    [Abstract] [Full Text] [Related]

  • 3. Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).
    Turner-Stokes L, Ashford S, Jacinto J, Maisonobe P, Balcaitiene J, Fheodoroff K.
    BMJ Open; 2016 Jun 17; 6(6):e011157. PubMed ID: 27315835
    [Abstract] [Full Text] [Related]

  • 4. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
    Săndulescu MI, Cinteză D, Poenaru D, Potcovaru CG, Păunescu H, Coman OA.
    Toxins (Basel); 2024 Mar 31; 16(4):. PubMed ID: 38668597
    [Abstract] [Full Text] [Related]

  • 5. [The study of the efficacy of Botulinum toxin type A in patients with poststroke upper-limb spasticity ULIS-II: an analysis of Russian patients].
    Khat'kova SE, Khasanova DR, Korenko LA, Antipova LN, Shperling LP, Popov DV, Pokhabov DV, Poznyakova EV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015 Mar 31; 115(7):89-97. PubMed ID: 26356520
    [Abstract] [Full Text] [Related]

  • 6. Assessing the effectiveness of upper-limb spasticity management using a structured approach to goal-setting and outcome measurement: First cycle results from the ULIS-III Study.
    Turner-Stokes L, Jacinto J, Fheodoroff K, Brashear A, Maisonobe P, Lysandropoulos A, Ashford S, Upper Limb International Spasticity-III (ULIS-III) study group.
    J Rehabil Med; 2021 Jan 01; 53(1):jrm00133. PubMed ID: 33206198
    [Abstract] [Full Text] [Related]

  • 7. [Treatment goals in patients with post-stroke upper limb spasticity following injection of botulinum toxin A : Results of the German-Austrian subgroup of the ULIS-II study].
    Fheodoroff K, Dressler D, Woldag H, Koßmehl P, Koch M, Maisonobe P, Reichel G.
    Nervenarzt; 2019 Apr 01; 90(4):361-370. PubMed ID: 30324541
    [Abstract] [Full Text] [Related]

  • 8. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
    López de Munain L, Valls-Solé J, Garcia Pascual I, Maisonobe P, on behalf of the VALGAS investigators group.
    Eur Neurol; 2019 Apr 01; 82(1-3):1-8. PubMed ID: 31726452
    [Abstract] [Full Text] [Related]

  • 9. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L, BoTULS investigators.
    Health Technol Assess; 2010 May 01; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [Abstract] [Full Text] [Related]

  • 10. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
    Nott MT, Barden HL, Baguley IJ.
    J Rehabil Med; 2014 Oct 01; 46(9):864-8. PubMed ID: 25074437
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity.
    Ghroubi S, Alila S, Elleuch W, Ayed HB, Mhiri C, Elleuch MH.
    Pan Afr Med J; 2020 Oct 01; 35():55. PubMed ID: 32523646
    [Abstract] [Full Text] [Related]

  • 12. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.
    Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Davies L, McCrory P, Hughes A.
    J Rehabil Med; 2010 Jan 01; 42(1):81-9. PubMed ID: 20111849
    [Abstract] [Full Text] [Related]

  • 13. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
    Ashford S, Turner-Stokes L.
    Disabil Rehabil; 2009 Jan 01; 31(3):220-6. PubMed ID: 18608366
    [Abstract] [Full Text] [Related]

  • 14. Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice.
    Turner-Stokes L, Fheodoroff K, Jacinto J, Maisonobe P, Zakine B.
    BMJ Open; 2013 Mar 18; 3(3):. PubMed ID: 23512837
    [Abstract] [Full Text] [Related]

  • 15. Results from the Upper Limb International Spasticity Study-II (ULISII):a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management.
    Turner-Stokes L, Fheodoroff K, Jacinto J, Maisonobe P.
    BMJ Open; 2013 Jun 20; 3(6):. PubMed ID: 23794582
    [Abstract] [Full Text] [Related]

  • 16. Factors influencing goal attainment in patients with post-stroke upper limb spasticity following treatment with botulinum toxin A in real-life clinical practice: sub-analyses from the Upper Limb International Spasticity (ULIS)-II Study.
    Fheodoroff K, Ashford S, Jacinto J, Maisonobe P, Balcaitiene J, Turner-Stokes L.
    Toxins (Basel); 2015 Apr 08; 7(4):1192-205. PubMed ID: 25856546
    [Abstract] [Full Text] [Related]

  • 17. The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia.
    Danchenko N, Johnston KM, Whalen J.
    J Med Econ; 2022 Apr 08; 25(1):919-929. PubMed ID: 35730362
    [Abstract] [Full Text] [Related]

  • 18. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P, Denis A, Gasq D, Chaleat-Valayer E, Yelnik A, Colin C, Botuloscope Group, Pérennou D.
    Ann Phys Rehabil Med; 2019 Jul 08; 62(4):207-213. PubMed ID: 31229700
    [Abstract] [Full Text] [Related]

  • 19. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R, Akturk S, Ersoy Y.
    Eur J Phys Rehabil Med; 2018 Oct 08; 54(5):738-744. PubMed ID: 29422486
    [Abstract] [Full Text] [Related]

  • 20. Real-world effectiveness of abobotulinumtoxinA (Dysport®) in adults with upper limb spasticity in routine clinical practice: an observational study.
    Sarzyńska-Długosz I, Szczepańska-Szerej A, Drużdż A, Łukomski T, Ochudło S, Fabian A, Sobolewski P, Mariańska K, Maciejewska J, Mulek E, Niedzielska A, Raymond R, Brzózka MM, Jessa-Jabłońska M.
    Neurol Neurochir Pol; 2020 Oct 08; 54(1):90-99. PubMed ID: 31956971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.